Gerresheimer AGGRRMF 66 OCF Yield % is 28.28 as of Jun. 29, 2026, which is 219% above its 10-year median of 8.86. GuruFocus rates GRRMF with a GF Score™ of 66/100 and a GF Value™ of $121.69 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Gerresheimer AG ranks better than 97.89% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Gerresheimer AG OCF Yield % Related Terms
Gerresheimer AG OCF Yield % Historical Data
* Premium members only.
The historical data trend for Gerresheimer AG's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Gerresheimer AG's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gerresheimer AG OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Gerresheimer AG's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gerresheimer AG (GRRMF) has a OCF Yield % of 28.28 as of Jun. 29, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Gerresheimer AG and its competitors. This is 219% above median its historical median of 8.86. Over the past decade, Gerresheimer AG's OCF Yield % has ranged from 5.29 to 43.32. According to the industry distribution chart, Gerresheimer AG ranks #18 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 2.1%.
Is Gerresheimer AG's OCF Yield % too high?
Gerresheimer AG's current OCF Yield % of 28.28 is 219% above median its 10-year median of 8.86. Over the past 10 years, this metric has ranged from a low of 5.29 to a high of 43.32. The Medical Devices & Instruments industry median OCF Yield % is 1.79. Gerresheimer AG's value of 28.28 is 1484.3% above this industry median. Based on the distribution chart, Gerresheimer AG ranks #18 out of 852 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Gerresheimer AG has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's OCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Gerresheimer AG ranks #18 out of 852 companies for OCF Yield %. This places Gerresheimer AG in the top 2% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.79. Gerresheimer AG's value of 28.28 is 1484.3% above this benchmark. Historically, Gerresheimer AG's own OCF Yield % has ranged from 5.29 to 43.32 over the past decade. While the company's 10-year median is 8.86 vs. the industry median of 1.79, Gerresheimer AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.79, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gerresheimer AG's current OCF Yield % of 28.28 is 1484.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Gerresheimer AG and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gerresheimer AG's current OCF Yield % is 28.28, which is 219% above median its own 10-year median of 8.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (GRRMF) is currently considered Possible Value Trap. The stock's GF Value™ is $121.69, compared to a current price of $32.10 — trading 73.6% below its estimated fair value. The current OCF Yield % is 28.28, which is 219% above median its 10-year median of 8.86 and 1484.3% above the Medical Devices & Instruments industry median of 1.79. Gerresheimer AG's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Gerresheimer AG (GRRMF), the current OCF Yield % is 28.28 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gerresheimer AG (GRRMF) Overvalued in 2026?
Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued.
The current stock price of $32.10 is trading 73.6% below its estimated GF Value™ of $121.69.
GuruFocus considers Gerresheimer AG to be Possible Value Trap.
Key valuation signals for GRRMF:
OCF Yield %: 28.28 (219% above median its 10-year median of 8.86)
GF Value™: $121.69 vs. price of $32.10 (73.6% below fair value)
Industry Position: 1484.3% above the Medical Devices & Instruments median (#18 of 852)
No single metric tells the full story. See the GRRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
66GF Score
Get the complete analysis for GRRMF
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRRMF has been successfully added to your 
